IGC Pharma, Inc. (IGC)
0.3019
0.00 (0.00%)
USD |
NYAM |
Apr 10, 16:00
0.30
0.00 (0.00%)
After-Hours: 20:00
IGC Pharma Shareholders Equity (Quarterly) : 7.423M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| electroCore, Inc. | -1.709M |
| Lantern Pharma, Inc. | 6.534M |
| 4D Molecular Therapeutics, Inc. | 505.66M |
| NRX Pharmaceuticals, Inc. | -15.94M |
| Acurx Pharmaceuticals, Inc. | 5.269M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.712M |
| Total Liabilities (Quarterly) | 2.289M |
| Debt to Equity Ratio | 0.0191 |
| Current Ratio | 0.8302 |
| Net Debt Paydown Yield | 0.12% |